Aardvark Therapeutics, Inc. AARD
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2025-02-13
Aardvark Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 1,295,677 | $4.9M | 5.94% |
| TWO SIGMA INVESTMENTS, LP | 163,355 | $615,848 | 0.75% |
| AQR CAPITAL MANAGEMENT LLC | 134,495 | $507,046 | 0.62% |
| MILLENNIUM MANAGEMENT LLC | 98,334 | $370,719 | 0.45% |
| RENAISSANCE TECHNOLOGIES LLC | 70,792 | $266,886 | 0.32% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.